Thalita Marcolan is a biologist with a Ph.D. in Cell Biology from the Federal University of Minas Gerais (UFMG), where she developed a 3D collagen-based scaffold with carbon nanotubes for bone regeneration. She has extensive experience in in vitro and in vivo experimental models, particularly applying nanotechnology to tissue engineering and cancer therapy. She is currently a postdoctoral fellow at the Biocell Lab (ICB-UFMG), supported by the RHAE/CNPq program in partnership with Pars Bio. Her research focuses on the cellular mechanisms of equine gonadotropic hormones in reproductive cell lines and the effects of magnetic nanoparticles on triple-negative breast cancer cells. Her current interests include tumor microenvironment modeling, drug delivery systems, and the identification of new therapeutic targets. She participates in collaborative initiatives such as the Minas Gerais Network for Theranostic Nanomedicine (FAPEMIG), the Tissue Engineering and Cell Therapy Network (REMETTEC), and the National Institute for Hepatology Research (INCT Hepatologia 360).